Saturday, October 18, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analysts Price Targets for Universal Health Services NYSE UHS

Elaine Mendonca by Elaine Mendonca
February 29, 2024
in Breaking News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Analyst Sarah James from Cantor Fitzgerald maintains her Underweight rating on Universal Health Services (NYSE: UHS) but has increased the price target to $156 from $148. As of February 29, 2024, the average price target for UHS stands at $173.83, with a high forecast of $190.00 and a low forecast of $161.00, suggesting a 5.79% change.

Other analysts have provided their own price targets, including Credit Suisse at $163.00, Barclays at $142.00, and Deutsche Bank at $155 (up from $145). The varying opinions from analysts indicate a range of perspectives on Universal Health Services’ stock performance and price targets.

Universal Health Services, Inc. (UHS) Stock Soars on February 29, 2024: Positive Performance and Strong Opening

On February 29, 2024, Universal Health Services, Inc. (UHS) saw a positive performance in the stock market. According to data from CNN Money, UHS was trading near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been performing well over the past year and is currently in an upward trend.

The price of UHS shares increased by $3.68 since the market last closed, representing a 2.28% rise. The stock opened at $163.13, which was $1.40 higher than its previous close. This strong opening suggests that investors were optimistic about the company’s prospects on that day.

Universal Health Services, Inc. (UHS) Reports Strong Financial Performance for 2023: Revenue and EPS Growth Signals Stability and Potential

On February 29, 2024, Universal Health Services, Inc. (UHS) reported its financial performance for the past year and the fourth quarter. According to data from CNN Money, UHS generated a total revenue of $14.28 billion over the past year, which represents a 6.59% increase compared to the previous year. In the fourth quarter alone, the company brought in $3.70 billion in revenue, showing a 3.95% increase from the previous quarter.

In terms of net income, UHS reported a total of $717.79 million for the year, up 6.36% from the previous year. However, in the fourth quarter, the net income remained flat at $216.38 million. Despite the quarterly stagnation, the annual increase in net income is a positive sign for the company’s financial health.

Earnings per share (EPS) also saw significant growth for UHS. The company reported an EPS of $10.23 for the year, marking an 11.92% increase from the previous year. In the fourth quarter, the EPS rose to $3.16, showing a substantial 31.79% increase from the previous quarter.

Overall, UHS’s stock performance on February 29, 2024, reflects a strong financial performance over the past year, with steady revenue growth and increasing earnings per share. Investors may view these positive indicators as a sign of the company’s stability and potential for future growth.

Tags: UHS
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Renewable energy

Imperial Oil AMEX IMO Stock Analysis Impressive Performance and Growth Potential

Food Retailers Stock Bull Market

Etsy Unusual Options Activity Analysis Potential Market Shift on the Horizon

Analyst Sentiments Towards Mirum Pharmaceuticals A Mixed Bag

Recommended

Formycon Stock

Formycon Stock: Q2 Slump Sparks Investor Skepticism

2 months ago
HIMS stock news

Ohio-based Institutional Investor Strs Ohio Decreases Stake in Hims & Hers Health, Inc.

2 years ago
Finance_ Chart up

Analyst Sarah James Bullish on DocGo with 11 Price Target

2 years ago
Exxon Mobil Stock

Can Exxon Mobil Navigate the Oil Price Downturn?

5 days ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Nike NIO Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Wall Street’s Stark Divide Over UnitedHealth Shares

Political Pressure Mounts as Trump Targets Weight-Loss Drug Pricing

Intel’s High-Stakes Transformation: Workforce Cuts and Price Hikes Signal Critical Juncture

LeonardoADR Shares Gain Momentum Ahead of Earnings Report

Enterprise Networking Specialist Gains AI-Driven Market Leadership

Autoliv’s Q3 2025 Results: A Critical Test for Investors

Trending

Robinhood Stock
Crypto Stocks

Robinhood Shares Experience Dramatic Trading Session

by Dieter Jaworski
October 18, 2025
0

Friday's trading session delivered a rollercoaster performance for Robinhood Markets, with the stock undergoing a remarkable transformation...

Abeona Therapeut. Stock

Biotech Firm Abeona Therapeutics Positioned for Significant Growth

October 18, 2025
Rocket Lab USA Stock

Institutional Investors Flock to Rocket Lab as Space Sector Soars

October 18, 2025
Unitedhealth Stock

Wall Street’s Stark Divide Over UnitedHealth Shares

October 18, 2025
Eli Lilly and Stock

Political Pressure Mounts as Trump Targets Weight-Loss Drug Pricing

October 18, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Robinhood Shares Experience Dramatic Trading Session
  • Biotech Firm Abeona Therapeutics Positioned for Significant Growth
  • Institutional Investors Flock to Rocket Lab as Space Sector Soars

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com